type-2-diabetes

Documents about type-2-diabetes

• A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes#148707ClinicalTrials.gov
• Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review#68179HAL (France)
• Early Type 2 diabetes risk prediction using explainable machine learning in a two-stage approach.#908NCBI PubMed Central
• Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia#123629ClinicalTrials.gov
• To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately#136256ClinicalTrials.gov
• Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy#136286ClinicalTrials.gov
• A Comparison of Exenatide and Insulin Glargine#140951ClinicalTrials.gov
• A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects#143765ClinicalTrials.gov
• Hypoglycaemia Risk Prediction Models for Type 2 Diabetes: A Systematic Review and Meta-Analysis.#145854NCBI PubMed Central
• A Drug Interaction Study of SY-004 Capsules in Healthy Subjects#146354ClinicalTrials.gov
• Incretin-based Drugs and the Risk of Heart Failure#148727ClinicalTrials.gov
• The Influence of Polypharmacy on Type 2 Diabetes Adverse Cardiovascular Outcomes in a Rural Cohort#150427bioRxiv / medRxiv
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes#162332ClinicalTrials.gov
• Bone Marrow Derived Stem Cell Transplantation in T2DM#172527ClinicalTrials.gov
• Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D#181712ClinicalTrials.gov
• Insulin Treatment in Diabetic Older People With Heart Failure.#184753ClinicalTrials.gov
• The Diabetes Staging System (DSS): A Pilot Study Assessing Feasibility, Provider Engagement and Implementation Challenges of a Novel Staging System for Type 2 Diabetes.#9148NCBI PubMed Central
• MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)#162405ClinicalTrials.gov
• Metabolomic and proteomic signatures of gestational diabetes predicting long-term risk of type 2 diabetes: a prospective cohort study in the UK Biobank#5038Europe PMC
• Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes#127835ClinicalTrials.gov
• Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes#160259ClinicalTrials.gov
• A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY#172511ClinicalTrials.gov
• A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM#141135ClinicalTrials.gov
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes#6883OpenAlex
• Social Network Interventions for Improving Dietary Adherence Among Adults With Type 2 Diabetes: A Systematic Review.#9248NCBI PubMed Central
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial#18541ClinicalTrials.gov
• Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM#121279ClinicalTrials.gov
• The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)#123410ClinicalTrials.gov
• Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age-Associated Gut-Brain Axis Profiles.#125280NCBI PubMed Central
• Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM#136227ClinicalTrials.gov
• Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors#143791ClinicalTrials.gov
• Functional genomics reveals mediators of beta cell survival in ER stress and type 2 diabetes risk#148844bioRxiv / medRxiv
• Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance#152578ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV) Food Insecurities#152613ClinicalTrials.gov
• A Specialized Diet for the Unique Metabolic Characteristics of Peripubertal African American Girls#154832ClinicalTrials.gov
• The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation#154866ClinicalTrials.gov
• Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy#154887ClinicalTrials.gov
• Personalized Medicine Interventions for Glycemic Control in Adults With Type 2 Diabetes: A Systematic Review.#170761NCBI PubMed Central
• Corneal and Tear Film Changes in Chinese Patients With Type 2 Diabetes#172484ClinicalTrials.gov
• GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial#172513ClinicalTrials.gov
• Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients#175090ClinicalTrials.gov
• Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control#180293ClinicalTrials.gov
• Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes#184802ClinicalTrials.gov
• Treatment preference for once-weekly versus once-daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials#5184Europe PMC
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)#67823ClinicalTrials.gov
• Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance#6909OpenAlex
• Impact of PharmaTE trial on glycemic control, diabetes knowledge, medication adherence, and quality of life in type 2 diabetes patients: a mixed-methods study protocol.#125679NCBI PubMed Central
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes#158161ClinicalTrials.gov
• Family influences on type 2 diabetes self-management: Perspectives of African American adults with food insecurity.#9414NCBI PubMed Central
• Patients' Perspectives on Telemedicine for Type 2 Diabetes in Primary Care: Systematic Review and Thematic Synthesis.#9633PubMed